Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs Clarithromycin for MAC Lung Disease (CLAZI)
NCT03236987Phase 3Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Feb 2018
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in Mycobacterium avium complex lung disease, sponsored by CHU Amiens-Picardie. Started Feb 2018; status: recruiting.
02
Drugs
azithromycin
03
Conditions
Mycobacterium avium complex lung disease
Beyond the preview
Go deeper on NCT03236987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03236987.